Company profile for PharmAust

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PharmAust is a clinical-stage biotechnology company specializing in the development of new therapeutics for both human and animal health applications. The company's focus includes the repurposing of monepantel for treating cancer in dogs and neurodegenerative diseases in humans. Monepantel is already an approved veterinary product for the treatment of worm infestations in sheep. The compound has shown potent inhibitory effects...
PharmAust is a clinical-stage biotechnology company specializing in the development of new therapeutics for both human and animal health applications. The company's focus includes the repurposing of monepantel for treating cancer in dogs and neurodegenerative diseases in humans. Monepantel is already an approved veterinary product for the treatment of worm infestations in sheep. The compound has shown potent inhibitory effects on the mTOR pathway in mammalian cells. Given the central role of the mTOR pathway in cell growth, proliferation in cancer cells, and neuronal degeneration.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
1 Kyle Way, Suite 116, Claremont
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/pharmaust-affirms-corporate-strategy-with-name-change-to-neurizon-therapeutics-302276997.html

PR NEWSWIRE
15 Oct 2024

https://www.prnewswire.com/news-releases/pharmaust-announces-positive-phase-1-mend-study-top-line-results-in-mnd--als-302074155.html

PR NEWSWIRE
28 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty